首页> 外文期刊>Arquivos de Gastroenterologia >O valor da amilase, obtido precocemente nos drenos abdominais, é teste útil em prever a ocorrência de fístula pancreática após duodenopancreatectomia: li??es aprendidas de um centro do Sul do Brasil
【24h】

O valor da amilase, obtido precocemente nos drenos abdominais, é teste útil em prever a ocorrência de fístula pancreática após duodenopancreatectomia: li??es aprendidas de um centro do Sul do Brasil

机译:早期从腹部引流中获得的淀粉酶的价值,对于预测十二指肠胰腺切除术后胰腺瘘的发生是有用的检验:从巴西南部一个中心吸取的经验教训

获取原文
       

摘要

BACKGROUND: Pancreatic fistula represents the most feared complication after pancreatoduodenectomies, being the major responsible for the high morbidity and mortality after this operation. Its incidence remains around 10% to 30%. In recent years, several authors have studied the value of amylase in abdominal drains fluid, measured at an early stage after the surgical procedure, as a useful tool to identify patients at risk of developing pancreatic fistula. OBJECTIVE: To analyze the value of early drain fluid amylase as a method to predict the occurrence and severity of postoperative pancreatic fistula in patients undergoing pancreatoduodenectomies. METHODS: We evaluated 102 prospective patients submitted to pancreatoduodenectomies from January 2013 to June 2017. The mensuration of amylase in abdominal drains was performed on days 1, 3, 5 and 7 in all patients. Patients were divided into three groups according to postoperative day 1 (POD1) results: values 270 U/L (group 1); between 271 and 5.000 U/L (group 2); and values 5.000 U/L (group 3). RESULTS: The incidence of pancreatic fistula was 25.5%, being 3.33%, 27.3% and 41.02% in the three groups, respectively. Compared with group 1, the risk of developing pancreatic fistula increased with increasing amylase values on POD1. Amylase values on POD1 and POD3 of patients with pancreatic fistula were higher than in the other ones without this complication ( P 0.001). In addition, in group 3, 37.5% of patients with pancreatic fistula evolved to death ( P 0.001). Finally, in this group, patients who died had drain fluid amylase values on POD1 significantly higher than the others in the same group ( P 0.001). CONCLUSION: Early drain fluid amylase value is a useful test to stratify patients in relation to the risk of developing pancreatic fistula after pancreatoduodenectomies, in addition to correlate with the severity of this complication.
机译:背景:胰瘘是胰十二指肠切除术后最令人担忧的并发症,是造成该手术后高发病率和高死亡率的主要原因。其发生率保持在10%到30%左右。近年来,几位作者研究了在外科手术后早期进行测量的腹腔引流液中淀粉酶的价值,将其作为识别有发生胰瘘风险的患者的有用工具。目的:探讨早期引流淀粉酶作为预测胰十二指肠切除术患者术后胰瘘发生和严重程度的方法的价值。方法:我们评估了2013年1月至2017年6月接受胰十二指肠切除术的102例预期患者。在所有患者的第1、3、5和7天进行腹腔引流的淀粉酶测定。根据术后第一天(POD1)的结果将患者分为三组:值<270 U / L(组1);在271至5.000 U / L之间(第2组);且值> 5.000 U / L(第3组)。结果:胰腺瘘的发生率为25.5%,三组分别为3.33%,27.3%和41.02%。与第1组相比,随着POD1上淀粉酶值的增加,发生胰腺瘘的风险增加。胰腺瘘患者的POD1和POD3上的淀粉酶值均高于其他无此并发症的患者(P <0.001)。此外,在第3组中,有37.5%的胰瘘患者发展为死亡(P <0.001)。最后,在该组中,死亡患者的POD1上的排出液淀粉酶值明显高于同一组中的其他患者(P <0.001)。结论:早期排泄液淀粉酶值是一项有用的测试,可将患者与胰十二指肠切除术后发生胰瘘的风险进行分层,此外还与并发症的严重程度相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号